Neuromuscular Disorder-Targeting Compound 1

• UNSPSC Description:

  Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/1H-Pyrazolo[3,4-g]quinoline,_4,4a,5,6,7,8,8a,9-octahydro-7-[_methylthio_methyl]-5-propyl-,__4aR,8aR_-rel-.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CCCN1CC(CSC)C[C@]2([H])CC(NN=C3)=C3C[C@@]12[H]

• Molecular Weight:

  279.44

• References & Citations:

  [1]Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  374538-23-5